Advertisement
Berita Valas
Another Week Of Dollar Weakness Despite Hawkish Fed Minutes
Renewed rate cut hopes dragged the U.S. Dollar lower during the week ended November 24, notwithstanding a hawkish tone in the Fed minutes released on Tuesday.
RTTNews |
605 days ago
Collegium Says Appeals Court Upholds PTAB's Finding Of Invalidity Of Purdue's 961 Patent Claim
Collegium Pharmaceutical, Inc. (COLL) announced Monday that the U.S. Court of Appeals for the Federal Circuit has upheld the judgment of the Patent Trial and Appeal Board (PTAB) in its final decision that Purdue's '961 patent, which Purdue Pharma L.P. has claimed is infringed by Xtampza ER, is invalid.
RTTNews
|
605 days ago
Outlook Therapeutics Announces Receipt Of Type A Meeting Official Minutes On ONS-5010 BLA
Biopharmaceutical company Outlook Therapeutics, Inc. (OTLK) announced Monday the receipt of the official minutes from the Type A meeting with the U.S. Food and Drug Administration (FDA) held in October 2023.
RTTNews
|
605 days ago
Bay Street Likely To Open On Cautious Note
Canadian shares are likely to open on a cautious note on Monday with investors awaiting a slew of key economic data from Canada and the U.S. Concerns about economic slowdown in China and weak crude oil prices are likely to weigh on the market.
RTTNews
|
605 days ago
U.S. Dollar Dips Ahead Of Key Data
The U.S. dollar weakened against its major counterparts in the European session on Monday on bets that the Federal Reserve is done hiking interest rates.
RTTNews
|
605 days ago
Summit Materials Plans To Offer $800.0 Million Aggregate Principal Amount Of Senior Notes Due 2031
Summit Materials, Inc. (SUM) announced Monday that its indirect subsidiaries Summit Materials, LLC and Summit Materials Finance Corp. intend to offer $800.0 million aggregate principal amount of Senior Notes due 2031.
RTTNews
|
605 days ago
Krystal Biotech Says EMA Validated MAA For VYJUVEK For Dystrophic Epidermolysis Bullosa
Biotechnology company Krystal Biotech, Inc. (KRYS) announced Monday that the Company's Marketing Authorization Application (MAA) to the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for VYJUVEK (beremagene geperpavec-svdt or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB) has been validated and is now under CHMP review. A CHMP opinion is anticipated in the second half of 2024.
RTTNews
|
605 days ago
more news
Genelux Says FDA Grants Fast Track Designation For Olvi-Vec To Treat Ovarian Cancer
Immuno-oncology company Genelux Corp. (GNLX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene nanivacirepvec) for the treatment of patients with platinum resistant/refractory ovarian cancer.
RTTNews
|
605 days ago
U.S. Black Friday Retail Sales Rise 2.5%
Black Friday retail sales in the United States were higher this year on top of double-digit growth experienced in 2022, according to Mastercard SpendingPulse. As per the payments technology company's report, which measures in-store and online retail sales across all forms of payment, U.S. retail sales on Friday, November 24 grew 2.5 percent year-over-year excluding automotive, not adjusted for in
RTTNews
|
605 days ago
European Shares Slip Into Red On China Concerns
European stocks were subdued on Monday as investors awaited key economic data from the U.S., Europe and China this week for directional cues.
RTTNews
|
605 days ago
FTSE 100 Slides As Energy Stocks Drag
U.K. stocks traded lower on Monday, with commodity stocks moving lower after data showed slowing industrial profit growth in China.
RTTNews
|
605 days ago
CAC 40 Struggles For Direction Ahead Of Key Data
French stocks were seeing modest gains on Monday as investors looked ahead to the release of U.S. European and Chinese PMIs, euro-zone inflation data and U.S. personal consumption numbers this week for additional clues on the growth and rate outlook.
RTTNews
|
605 days ago
DAX Marginally Lower; Lagarde Speech Eyed
German stocks were little changed in cautious trade on Monday as investors awaited comments from European Central Bank's President Christine Lagarde on monetary policy before a committee of European Parliament.
RTTNews
|
605 days ago
Stay up to date!
Add Berita to your browser
Add To Chrome
